Document 2955 DOCN M94A2955 TI AIDS associated diarrhea. Preliminary results of a study. DT 9412 AU Tumbarello M; Ventura G; Tacconelli E; Scoppettuolo G; Papi G; Cauda R; Istituto Malattie Infettive, Universita Cattolica Roma, Italy. SO Int Conf AIDS. 1994 Aug 7-12;10(1):187 (abstract no. PB0175). Unique Identifier : AIDSLINE ICA10/94369620 AB OBJECTIVE: To evaluate the frequency, microbiological agents, clinical findings and impact on the quality of life of diarrhea in AIDS patients (pts). METHODS: All consecutive AIDS pts admitted to our ward from 7-1993 to 2-1994 were included in the study. Diarrhea was defined as 3 or more daily bowel movements for more than 2 consecutive days. From each pts with diarrhea stool samples were screened for bacteria and parasites. An adapted version of the Functional Living Index for Cancer test was used to evaluate the quality of life in AIDS pts with (group A) or without (group B) diarrhea in comparison to a randomly selected group of HIV asymptomatic individuals (group C). RESULTS: 44 patients with AIDS related diarrhea were observed (29 M and 15 F, mean age 32 +/- 4 yrs.). In 24 patients diarrhea was related to one or more enteric pathogens, namely Cryptosporidium (29%), NT-Salmonella (21%), Mycobacterium avium complex (21%), C. difficile (17%) and Campylobacter (12.5%). No specific agent responsible of diarrhea was identified in 45% of the cases. The response to antimicrobial therapy was favorable in 68% of cases. 11 patients with refractory diarrhea were treated with antidiarrhoeal therapy, i.e. loperamide or octeotride. The quality of life resulted low in group A and B (p < 0.05 versus group C); in particular, the pts of group A had the lower quality of life (p = ns versus group B). CONCLUSIONS: These preliminary data suggest that diarrhea is a rilevant issue that can negatively influences the quality of life of AIDS pts. DE Adult AIDS-Related Opportunistic Infections/DIAGNOSIS/DRUG THERAPY/ *ETIOLOGY Diagnosis, Differential Diarrhea/DRUG THERAPY/*ETIOLOGY Female Human Loperamide/THERAPEUTIC USE Male Octreotide/THERAPEUTIC USE Quality of Life MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).